ResMed (RMD) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended September 2024, ResMed (RMD) reported revenue of $1.22 billion, up 11.1% over the same period last year. EPS came in at $2.20, compared to $1.64 in the year-ago quarter.The reported revenue represents a surprise of +2.98% over the Zacks Consensus Estimate of $1.19 billion. With the consensus EPS estimate being $2.03, the EPS surprise was +8.37%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their ne ...